Optimization of cyclosporine exposure utilizing C2 level monitoring in de novo renal transplant recipients: the toronto general hospital experience
- 1 November 2001
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 33 (7-8), 3098-3099
- https://doi.org/10.1016/s0041-1345(01)02320-x
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Approaching the Therapeutic Window for Cyclosporine in Kidney TransplantationJournal of the American Society of Nephrology, 2001
- Neoral use in the renal transplant recipientTransplantation Proceedings, 2000
- IMPROVED CLINICAL OUTCOMES FOR LIVER TRANSPLANT RECIPIENTS USING CYCLOSPORINE BLOOD LEVEL MONITORING BASED ON TWO-HOUR POST-DOSE LEVELS.Transplantation, 2000
- A COMPARISON OF RABBIT ANTITHYMOCYTE SERUM ANE OKT3 AS PROPHYLAXIS AGAINST RENAL ALLOGRAFT REJECTIONTransplantation, 1994